Serotonergic modulation of excitatory synapse formation and maturation during development
发育过程中兴奋性突触形成和成熟的血清素调节
基本信息
- 批准号:10307105
- 负责人:
- 金额:$ 38.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-01 至 2025-10-31
- 项目状态:未结题
- 来源:
- 关键词:AgeAnimal ModelAntidepressive AgentsBehaviorBehavioralBloodBrainBrain DiseasesCalciumCerebral cortexChronicColorCommunicationDataDendritesDendritic SpinesDevelopmentDiseaseElectrophysiology (science)Environmental Risk FactorExcitatory SynapseExposure toFluoxetineFunctional disorderGeneticGlutamatesGoalsGrowthHumanImageImpairmentIncidenceIndividualInterneuronsInvadedInvestigationKnowledgeLesionLifeLiteratureMeasuresMediatingMolecularMusNeurodevelopmental DisorderNeuronal DysfunctionNeuronsNeurotransmittersOutcomePathogenesisPathologyPharmaceutical PreparationsPharmacologyPhysiologicalPrefrontal CortexPregnancyPregnant WomenPresynaptic TerminalsReceptor ActivationResearchResolutionRiskRoleSelective Serotonin Reuptake InhibitorSerotonergic SystemSerotoninSignal TransductionSiteSomatostatinStimulusSymptomsSynapsesTestingTimeVertebral columnWorkautism spectrum disorderautisticcell typecognitive processdensityexperienceexperimental studyfetalfluorescence lifetime imaginggamma-Aminobutyric Acidhippocampal pyramidal neuronimprovedinfancyinsightneonatal exposureneural circuitneuronal excitabilitynovelnovel therapeutic interventionoffspringoptogeneticspostnatalpostsynapticprenatal exposurepsychologicreceptorresponsesocialsocial deficitsspatiotemporalsynaptic functionsynaptogenesistooltwo-photon
项目摘要
Project Summary
Autism Spectrum Disorders (ASDs) comprise a group of severe neurodevelopmental disorders that are typified
by communication deficits and social impairment. Given that the onset of symptoms occurs by the age of 3, it is
largely agreed that neuronal dysfunction arises during early brain development. A developing brain shows a
remarkable capacity for plastic changes in response to experiences; thus, its development is most vulnerable to
the environmental factors that can derail normal brain function. In utero exposure to drugs that raise blood 5HT
levels, including selective serotonin reuptake inhibitors (SSRIs), has demonstrated behavioral and psychological
deficits in offspring that closely resemble autistic symptoms in both animals models and human studies. In order
to understand how these alterations arise, it is necessary to first understand the basic mechanisms of
serotonergic modulation of brain function. Formation and stabilization of excitatory synapses are known to be
essential for the initial establishment of functional neural circuits. Conversely, disrupted synapse development
impairs neuron function and is thought to underlie the pathology of multiple neurodevelopmental disorders. PFC
is densely innervated by serotonergic axon terminals and associated with higher cognitive processes that may
be disrupted in illnesses such as ASDs. Despite a wealth of literature examining the role of 5HT in modulating
behavior and in the pathogenesis of brain disorders, little is known at the cellular and molecular level about the
role of 5HT in early cortical development, and particularly the postsynaptic 5HT mechanisms that modulate
synapse development in the developing PFC. In the present study, we utilize a novel combination of tools
including two-color, two-photon uncaging that enables precise release of 5HT and glutamate neurotransmitters,
calcium imaging, electrophysiology, and optogenetic stimulation of genetically-targeted 5HT neurons to test our
central hypothesis that 5HT signaling promotes the initiation of excitatory synapse formation and controls the
maturation of excitatory synapses during brain development. Guided by strong preliminary data, we will examine
this hypothesis in two specific aims: 1) Determine the role of 5HT signaling in lowering the threshold for induction
of activity-dependent synapse formation. 2) Define the actions of 5HT on activity-dependent, input-specific and
heterosynaptic spine stabilization. Results from these studies will further our understanding of the unique and
detailed mechanisms by which 5HT regulates brain development, with critical relevance to cellular underpinnings
of neurodevelopmental disorders. In the U.S., approximately 13% of pregnant women use SSRIs, which typically
increase fetal 5HT levels. We expect that our results will highlight new avenues into the investigation of the
pathophysiology underlying neurodevelopmental disorders resulting from early perturbation of 5HT signaling.
项目摘要
自闭症谱系障碍(ASDS)包括一组严重的神经发育障碍
通过沟通不足和社会障碍。鉴于症状发作到3岁时发生,这是
在很大程度上同意,在早期大脑发育过程中会出现神经元功能障碍。一个发育的大脑显示
塑料变化的显着能力响应经验;因此,它的发展最容易受到影响
可能使正常脑功能脱轨的环境因素。在子宫内暴露于升血5HT的药物
包括选择性5-羟色胺再摄取抑制剂(SSRI)在内的水平已表现出行为和心理
在动物模型和人类研究中,后代的缺陷与自闭症症状非常相似。为了
要了解这些改变是如何出现的,有必要首先了解
脑功能的血清素能调节。已知兴奋性突触的形成和稳定是
最初建立功能性神经回路至关重要。相反,突触的破坏
损害神经元的功能,被认为是多种神经发育障碍的病理。 PFC
通过血清素能轴突末端密集地支配,并与较高的认知过程相关
在ASD等疾病中受到破坏。尽管大量文献研究了5HT在调节中的作用
行为和脑部疾病的发病机理,在细胞和分子水平上几乎不知道
5HT在早期皮质发育中的作用,尤其是调节后突触后的5HT机制
发育中的PFC突触发展。在本研究中,我们利用了新的工具组合
包括两种颜色的两光子脉冲,可以精确释放5HT和谷氨酸神经递质,
钙成像,电生理学和遗传靶向5HT神经元的光遗传学刺激测试我们
中心假设,即5HT信号传导促进了兴奋性突触形成的启动,并控制了
大脑发育过程中兴奋性突触的成熟。在强大的初步数据的指导下,我们将检查
这两个特定目的的假设:1)确定5HT信号在降低诱导阈值中的作用
活动依赖性突触形成。 2)定义5HT对活动依赖性,输入特异性和
异突触脊柱稳定。这些研究的结果将进一步了解我们对独特和
5HT调节大脑发育的详细机制,与细胞基础有关
神经发育障碍。在美国,大约13%的孕妇使用SSRI,通常
增加胎儿5HT水平。我们希望我们的结果将重点介绍新的途径
病理生理的基础神经发育障碍是由于5HT信号的早期扰动而导致的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Won Chan Oh其他文献
Won Chan Oh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Won Chan Oh', 18)}}的其他基金
A new approach to understanding cognitive disabilities in Down syndrome
理解唐氏综合症认知障碍的新方法
- 批准号:
10725562 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Dissecting neural circuits underlying early life stress-induced PFC dysfunction
剖析早期生活压力引起的 PFC 功能障碍的神经回路
- 批准号:
10189334 - 财政年份:2021
- 资助金额:
$ 38.37万 - 项目类别:
Dissecting neural circuits underlying early life stress-induced PFC dysfunction
剖析早期生活压力引起的 PFC 功能障碍的神经回路
- 批准号:
10381735 - 财政年份:2021
- 资助金额:
$ 38.37万 - 项目类别:
Serotonergic modulation of excitatory synapse formation and maturation during development
发育过程中兴奋性突触形成和成熟的血清素调节
- 批准号:
10096510 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Serotonergic modulation of excitatory synapse formation and maturation during development
发育过程中兴奋性突触形成和成熟的血清素调节
- 批准号:
10513816 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Human brain multi-omics to decipher major depression pathophysiology
人脑多组学破译重度抑郁症病理生理学
- 批准号:
10715962 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Estradiol treatment of stress-related psychiatric disorders in Veterans
雌二醇治疗退伍军人压力相关精神疾病
- 批准号:
10484783 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
The role of metabotropic mGluR2 receptors in the chronic cognitive and behavioral effects of blast exposure
代谢型 mGluR2 受体在爆炸暴露的慢性认知和行为影响中的作用
- 批准号:
10538740 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别:
Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stage
使用四氢孕酮探讨围绝经期女性抑郁症的行为和神经生物学机制
- 批准号:
10557128 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别:
New Therapies for Essential Tremor from Cannabidiols Mechanisms
大麻二酚机制治疗特发性震颤的新疗法
- 批准号:
10640964 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别: